Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 598 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Aardvark Therapeutics, Inc. Common Stock
Market Cap
$109.53M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
N/A
Market Cap
$109.07M
Operating Margin
-6.06%
TTM Avg
-25.69%
3Y Avg
-34.32%
5Y Avg
-39.92%
Market Cap
$111.56M
Operating Margin
-265.64%
TTM Avg
-359.98%
3Y Avg
-411.27%
5Y Avg
-4203.28%
Market Cap
$112.01M
Operating Margin
-255.05%
TTM Avg
-370.20%
3Y Avg
-218.02%
5Y Avg
-145.34%
Market Cap
$113.70M
Operating Margin
-1054.82%
TTM Avg
-1057.23%
3Y Avg
-4752.68%
5Y Avg
-4082.42%
Market Cap
$106.58M
Operating Margin
28.39%
TTM Avg
14.20%
3Y Avg
7.10%
5Y Avg
4.73%
Market Cap
$106.72M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-1578.22%
Market Cap
$108.40M
Operating Margin
-6.27%
TTM Avg
-11.63%
3Y Avg
-15.25%
5Y Avg
-16.56%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aardvark Therapeutics, Inc. Common Stock (AARD) | $109.53M | 0.00% | 0.00% | 0.00% | N/A |
| Apyx Medical Corporation (APYX)vs › | $109.07M | -6.06% | -25.69% | -34.32% | -39.92% |
| Foghorn Therapeutics Inc. (FHTX)vs › | $111.56M | -265.64% | -359.98% | -411.27% | -4203.28% |
| Coya Therapeutics, Inc. (COYA)vs › | $112.01M | -255.05% | -370.20% | -218.02% | -145.34% |
| Lucid Diagnostics Inc. (LUCD)vs › | $113.70M | -1054.82% | -1057.23% | -4752.68% | -4082.42% |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $106.58M | 28.39% | 14.20% | 7.10% | 4.73% |
| Immunic, Inc. (IMUX)vs › | $106.66M | 0.00% | 0.00% | 0.00% | 0.00% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $106.72M | 0.00% | 0.00% | 0.00% | -1578.22% |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $108.40M | -6.27% | -11.63% | -15.25% | -16.56% |
| BGM Group Ltd. (BGM)vs › | $105.94M | -33.18% | -17.71% | -9.45% | -4.00% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
